FERROUS FUMARATE AND POLYSACCHRIDE IRON COMPLEX AND FOLIC ACID

FERROUS FUMARATE AND POLYSACCHRIDE IRON COMPLEX AND FOLIC ACID was reported 96 times

FERROUS FUMARATE AND POLYSACCHRIDE IRON COMPLEX AND FOLIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DACRYOCYSTITIS 1 0.0065
1 TUMOUR MARKER ABNORMAL 1 0.0030
2 PERIORBITAL CELLULITIS 1 0.0019
3 OESOPHAGEAL IRRITATION 1 0.0017
4 CELLULITIS ORBITAL 1 0.0017
5 MEDICAL DEVICE SITE INFECTION 1 0.0016
6 CERVICAL RADICULOPATHY 1 0.0014
7 CARDIAC ENZYMES INCREASED 1 0.0014
8 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
9 CRANIOFACIAL FRACTURE 1 0.0012
10 RETINAL EXUDATES 1 0.0011
11 DRUG EFFECT VARIABLE 1 0.0009
12 FOCAL DYSCOGNITIVE SEIZURES 1 0.0009
13 DACRYOSTENOSIS ACQUIRED 1 0.0008
14 MENINGITIS VIRAL 1 0.0007
15 NAIL INFECTION 1 0.0007
16 HEAT STROKE 1 0.0007
17 MEDICAL DEVICE IMPLANTATION 1 0.0006
18 NASAL ULCER 1 0.0006
19 HAEMATOCRIT INCREASED 1 0.0004
20 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
21 BLOOD CHLORIDE DECREASED 1 0.0004
22 NASAL DISORDER 1 0.0004
23 DRUG TOLERANCE DECREASED 1 0.0004
24 EMERGENCY CARE 1 0.0003
25 CERVICAL VERTEBRAL FRACTURE 1 0.0003
26 LOSS OF CONTROL OF LEGS 1 0.0003
27 NAIL DISCOLOURATION 1 0.0003
28 SPINAL STENOSIS 1 0.0002
29 TONGUE DISCOMFORT 1 0.0002
30 HAEMORRHAGIC ANAEMIA 1 0.0002
31 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
32 LOCALISED OEDEMA 1 0.0002
33 VAGINAL INFECTION 1 0.0002
34 ENDOMETRIOSIS 1 0.0002
35 TUMOUR MARKER INCREASED 1 0.0002
36 PERIPHERAL VASCULAR DISORDER 1 0.0002
37 CHOLECYSTITIS ACUTE 1 0.0002
38 MACULAR DEGENERATION 2 0.0002
39 TYPE 1 DIABETES MELLITUS 1 0.0002
40 PRE-EXISTING CONDITION IMPROVED 1 0.0002
41 MENINGITIS 1 0.0001
42 APHONIA 2 0.0001
43 DIVERTICULUM 1 0.0001
44 GENERAL SYMPTOM 1 0.0001
45 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
46 STENT PLACEMENT 1 0.0001
47 MENSTRUAL DISORDER 1 0.0001
48 INADEQUATE ANALGESIA 1 0.0001
49 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
50 HEAD DISCOMFORT 2 0.0001
51 GASTROINTESTINAL INFECTION 1 0.0001
52 ANAL INCONTINENCE 1 0.0001
53 PRODUCT DISTRIBUTION ISSUE 1 0.0001
54 ACUTE RESPIRATORY FAILURE 2 0.0001
55 DIZZINESS POSTURAL 1 0.0001
56 HOSPICE CARE 1 0.0001
57 INABILITY TO AFFORD MEDICATION 1 0.0001
58 BRAIN INJURY 1 0.0001
59 VAGINAL DISCHARGE 1 0.0001
60 TEMPERATURE INTOLERANCE 1 0.0001
61 INJECTION SITE DISCOMFORT 1 0.0001
62 BREAST CANCER METASTATIC 1 0.0001
63 BLOOD CALCIUM DECREASED 1 0.0001
64 BLOOD IRON DECREASED 1 0.0001
65 HYPERLIPIDAEMIA 1 0.0001
66 SCHIZOPHRENIA 1 0.0001
67 OSTEONECROSIS OF JAW 2 0.0001
68 PHARYNGITIS 1 0.0001
69 PLATELET COUNT INCREASED 1 0.0001
70 IMMUNE SYSTEM DISORDER 1 0.0001
71 MENTAL STATUS CHANGES 2 0.0001
72 ORAL DISCOMFORT 1 0.0001
73 COORDINATION ABNORMAL 1 0.0001
74 MASS 1 0.0001
75 RED BLOOD CELL COUNT DECREASED 2 0.0001
76 URINARY INCONTINENCE 2 0.0001
77 BLOOD POTASSIUM DECREASED 2 0.0001
78 BLOOD COUNT ABNORMAL 1 0.0001
79 EJECTION FRACTION DECREASED 1 0.0001
80 METASTASES TO BONE 1 0.0001
81 FLUID RETENTION 3 0.0001
82 NEOPLASM PROGRESSION 2 0.0001
83 ORTHOSTATIC HYPOTENSION 1 0.0001
84 LOCAL SWELLING 1 0.0001
85 RASH MACULAR 2 0.0001
86 HEPATIC STEATOSIS 1 0.0001
87 BLOOD SODIUM DECREASED 1 0.0001
88 MUSCULOSKELETAL DISORDER 1 0.0001
89 PLASMA CELL MYELOMA 2 0.0001
90 SKIN FISSURES 1 0.0001
91 STOMATITIS 3 0.0000
92 FEEDING DISORDER 1 0.0000
93 TASTE DISORDER 1 0.0000
94 PULMONARY HYPERTENSION 1 0.0000
95 KNEE ARTHROPLASTY 1 0.0000
96 IRRITABLE BOWEL SYNDROME 1 0.0000
97 PRODUCT AVAILABILITY ISSUE 1 0.0000
98 SKIN DISCOLOURATION 2 0.0000
99 MUSCLE TWITCHING 1 0.0000
100 HYPOKALAEMIA 2 0.0000
101 COGNITIVE DISORDER 2 0.0000
102 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
103 DEMENTIA 1 0.0000
104 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
105 HYPERSOMNIA 1 0.0000
106 RESPIRATORY DISORDER 1 0.0000
107 APHASIA 1 0.0000
108 HIP FRACTURE 1 0.0000
109 DEEP VEIN THROMBOSIS 2 0.0000
110 AMNESIA 2 0.0000
111 STAPHYLOCOCCAL INFECTION 1 0.0000
112 HAEMOGLOBIN DECREASED 3 0.0000
113 MEMORY IMPAIRMENT 4 0.0000
114 HYPOXIA 1 0.0000
115 COLITIS 1 0.0000
116 CHRONIC KIDNEY DISEASE 2 0.0000
117 PERIPHERAL SWELLING 4 0.0000
118 DISORIENTATION 1 0.0000
119 JOINT SWELLING 3 0.0000
120 VISUAL IMPAIRMENT 3 0.0000
121 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
122 LOSS OF CONSCIOUSNESS 3 0.0000
123 BALANCE DISORDER 2 0.0000
124 ADVERSE DRUG REACTION 2 0.0000
125 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
126 ABDOMINAL PAIN 5 0.0000
127 CARDIAC DISORDER 2 0.0000
128 COMA 1 0.0000
129 BLOOD GLUCOSE DECREASED 1 0.0000
130 ATRIAL FIBRILLATION 2 0.0000
131 DYSPEPSIA 2 0.0000
132 SYNCOPE 2 0.0000
133 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
134 NERVOUSNESS 1 0.0000
135 DEPRESSED MOOD 1 0.0000
136 PLATELET COUNT DECREASED 2 0.0000
137 RASH PRURITIC 1 0.0000
138 CONSTIPATION 4 0.0000
139 TREATMENT NONCOMPLIANCE 1 0.0000
140 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
141 WEIGHT DECREASED 5 0.0000
142 PANCYTOPENIA 1 0.0000
143 BLISTER 1 0.0000
144 FLATULENCE 1 0.0000
145 URINARY TRACT INFECTION 3 0.0000
146 HERPES ZOSTER 1 0.0000
147 DECREASED APPETITE 4 0.0000
148 DYSPHONIA 1 0.0000
149 SURGERY 1 0.0000
150 DISCOMFORT 1 0.0000
151 NASOPHARYNGITIS 3 0.0000
152 PRODUCT DOSE OMISSION 1 0.0000
153 BLOOD CREATININE INCREASED 1 0.0000
154 PSORIASIS 2 0.0000
155 INFUSION RELATED REACTION 1 0.0000
156 RENAL FAILURE 2 0.0000
157 BLOOD PRESSURE DECREASED 1 0.0000
158 FALL 5 0.0000
159 HYPOTENSION 3 0.0000
160 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
161 SLEEP DISORDER 1 0.0000
162 HYPERTENSION 3 0.0000
163 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
164 THERAPY INTERRUPTED 1 0.0000
165 MOBILITY DECREASED 1 0.0000
166 DYSGEUSIA 1 0.0000
167 HYPOAESTHESIA 2 0.0000
168 HALLUCINATION 1 0.0000
169 HOT FLUSH 1 0.0000
170 DIABETES MELLITUS 1 0.0000
171 ARTHRITIS 1 0.0000
172 PARAESTHESIA 2 0.0000
173 INJECTION SITE BRUISING 1 0.0000
174 INJECTION SITE HAEMORRHAGE 1 0.0000
175 CARDIAC FAILURE 1 0.0000
176 CARDIAC FAILURE CONGESTIVE 1 0.0000
177 DIARRHOEA 8 0.0000
178 DRY MOUTH 1 0.0000
179 RENAL IMPAIRMENT 1 0.0000
180 CEREBROVASCULAR ACCIDENT 2 0.0000
181 FATIGUE 9 0.0000
182 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
183 GASTROINTESTINAL DISORDER 1 0.0000
184 SUICIDAL IDEATION 1 0.0000
185 ADVERSE EVENT 1 0.0000
186 OROPHARYNGEAL PAIN 1 0.0000
187 SWELLING 1 0.0000
188 ASTHENIA 4 0.0000
189 DYSPNOEA 6 0.0000
190 NEUROPATHY PERIPHERAL 1 0.0000
191 ANAEMIA 2 0.0000
192 PRODUCT DOSE OMISSION ISSUE 3 0.0000
193 PAIN IN EXTREMITY 3 0.0000
194 SINUSITIS 1 0.0000
195 ARTHRALGIA 4 0.0000
196 ABDOMINAL DISTENSION 1 0.0000
197 INFLUENZA 1 0.0000
198 WEIGHT INCREASED 2 0.0000
199 ASTHMA 1 0.0000
200 MUSCULAR WEAKNESS 1 0.0000
201 DEPRESSION 2 0.0000
202 SEIZURE 1 0.0000
203 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
204 CHILLS 1 0.0000
205 FEELING ABNORMAL 2 0.0000
206 OEDEMA PERIPHERAL 1 0.0000
207 HYPERHIDROSIS 1 0.0000
208 NAUSEA 6 0.0000
209 DEHYDRATION 1 0.0000
210 PRODUCT QUALITY ISSUE 1 0.0000
211 ANXIETY 2 0.0000
212 CONDITION AGGRAVATED 2 0.0000
213 BLOOD PRESSURE INCREASED 1 0.0000
214 ACUTE KIDNEY INJURY 1 0.0000
215 INJECTION SITE PAIN 2 0.0000
216 CONFUSIONAL STATE 1 0.0000
217 DIZZINESS 3 0.0000
218 NO ADVERSE EVENT 1 0.0000
219 MUSCLE SPASMS 1 0.0000
220 GAIT DISTURBANCE 1 0.0000
221 SOMNOLENCE 1 0.0000
222 PAIN 3 0.0000
223 ERYTHEMA 1 0.0000
224 HEADACHE 3 0.0000
225 DEATH 4 0.0000
226 MALAISE 2 0.0000
227 INCORRECT DOSE ADMINISTERED 1 0.0000
228 BACK PAIN 1 0.0000
229 VOMITING 2 0.0000
230 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
231 INSOMNIA 1 0.0000
232 PRURITUS 1 0.0000
233 OFF LABEL USE 1 0.0000
234 DRUG INEFFECTIVE 1 0.0000